Prior view was $410M-$450M. Guidance reduction is due to the company’s decision to remove any non-migrant municipal population health revenue from its 2025 guidance. Revenue expectations from the company’s Medical Transportation and Payer & Provider businesses and remaining migrant services healthcare work are unchanged.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO: